Search Within

Population Sciences Research Program

  1. "Solid Tumor Oncology Division"
  2. "Zhigang Zhang"
  3. "Atif Khan"
Formats
  1. Meeting Abstract (5)
  2. Journal Article (4)
Groups
  1. Biostatistics Service (9)
  2. Department of Medicine (9)
  3. Epidemiology and Biostatistics (9)
  4. GSK Faculty (9)
  5. Radiation Oncology, Department of (9)
  6. Solid Tumor Oncology Division (9)

More Groups

People
  1. Atif Khan (9)
  2. Simon Powell (9)
  3. Zhigang Zhang (9)
  4. Erin Gillespie (8)
  5. Jessica Flynn (7)
  6. Lior Braunstein (7)

More People

Years
  1. 2022 (1)
  2. 2021 (4)
  3. 2020 (2)
  4. 2019 (2)
Publications
  1. International Journal of Radiation Oncology, Biology, Physics (5)
  2. JAMA Network Open (1)
  3. JCO Precision Oncology (1)
  4. JNCI: Journal of the National Cancer Institute (1)
  5. Journal of Clinical Oncology (1)
Publishers
  1. Elsevier Inc. (5)
  2. American Society of Clinical Oncology (2)
  3. American Medical Association (1)
  4. Oxford University Press (1)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Final analysis of consolidative use of radiotherapy to block (CURB) oligoprogression trial - A randomized study of stereotactic body radiotherapy for oligoprogressive metastatic lung and breast cancers
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Eng, J.; Yeh, R.; Girshman, J.; Das, J.; Gelblum, D.; Xu, A. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Consolidative use of radiotherapy to block (CURB) oligoprogression: Interim analysis of the first randomized study of stereotactic body radiotherapy in patients with oligoprogressive metastatic cancers of the lung and breast
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Shepherd, A. F.; Eng, J.; Gelblum, D.; Xu, A. J.; Namakydoust, A.; Iqbal, A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save
  • Tolerability of breast radiotherapy among carriers of ATM germline variants
    Journal Article

    Modlin, L. A.; Flynn, J.; Zhang, Z.; Cahlon, O.; Mueller, B.; Khan, A. J.; Gillespie, E. F.; McCormick, B.; Stadler, Z. K.; Robson, M. E.; more...
    JCO Precision Oncology (2021)

    Fulltext@MSK | Save
  • Pathogenic ATM mutations in cancer and a genetic basis for radiotherapeutic efficacy
    Journal Article

    Pitter, K. L.; Casey, D. L.; Lu, Y. C.; Hannum, M.; Zhang, Z.; Song, X.; Pecorari, I.; McMillan, B.; Ma, J.; Samstein, R. M.; more...
    JNCI: Journal of the National Cancer Institute (2021)

    Fulltext@MSK | Save
  • 10-year breast cancer outcomes in women ≤35 years of age
    Journal Article

    Billena, C.; Wilgucki, M.; Flynn, J.; Modlin, L.; Tadros, A.; Razavi, P.; Braunstein, L. Z.; Gillespie, E.; Cahlon, O.; McCormick, B.; more...
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save
  • Analysis of racial disparities in overall survival and disease recurrence in patients with breast cancer diagnosed at age 35 or younger
    Meeting Abstract

    Billena, C.; Wilgucki, M.; Modlin, L. A.; Flynn, J.; Tadros, A. B.; Razavi, P.; Braunstein, L. Z.; Gillespie, E. F.; Cahlon, O.; Xu, A. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • Regional lymph node involvement among patients with de novo metastatic breast cancer
    Journal Article

    Bitencourt, A.; Rossi Saccarelli, C.; Morris, E. A.; Flynn, J.; Zhang, Z.; Khan, A.; Gillespie, E.; Cahlon, O.; Mueller, B.; Cuaron, J. J.; more...
    JAMA Network Open (2020)

    Fulltext@MSK | Save
  • Breast radiotherapy among ATM-mutation carriers
    Meeting Abstract

    Modlin, L. A.; Flynn, J.; Zhang, Z.; Mueller, B.; Khan, A. J.; Gillespie, E. F.; Cahlon, O.; McCormick, B.; Robson, M. E.; Powell, S. N.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Breast cancer in patients age <= 35 years: Overall survival, disease-free survival, secondary malignancies, and contralateral breast cancers rates across 10 years of follow-up
    Meeting Abstract

    Khan, A. J.; Billena, C.; Wilgucki, M.; Flynn, J.; Modlin, L. A.; Tadros, A. B.; Razavi, P.; Braunstein, L. Z.; Gillespie, E. F.; Cahlon, O.; more...
    International Journal of Radiation Oncology, Biology, Physics (2019)

    Fulltext@MSK | Save